BEIJING - China will not include Pfizer Inc’s Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as the US firm quoted a high price for the Covid-19 drug, China’s Healthcare Security Administration said on Sunday.
Inclusion on the list means a drug is accessible via state insurance schemes, which will boost volumes but comes with the condition that manufacturers lower prices. Past rounds have seen drugmakers cut prices by as much as 62 per cent after negotiations with officials.The NHSA said Paxlovid would continue to be eligible to be paid for by state medical insurance until the current planned end-date to the temporary measures of March 31.
The sudden loosening of restrictions has fueled a giant wave of infections and prompted many to turn to underground channels to procure remedies such as Paxlovid, which a clinical trial has found to have reduced hospitalisations in high-risk patients by around 90 per cent.
Lol Pfizer sucks
straits_times Not surprising why it failed.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: asiaonecom - 🏆 10. / 59 Read more »